InsidersTradesSigma
基于 2 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Browse the detailed record of transactions filed by Smith Nicholas Conrad. Insider active across 1 company, notably Alto Neuroscience, Inc.. Aggregated, 4 reports have been recorded. Split: 2 buys · 0 sell. Total volume traded: €47k. History available since 6 February 2024. The latest transaction was disclosed on 1 March 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Smith Nicholas Conrad is a declarant and he is Chief Financial Officer & CBO at Alto Neuroscience, Inc. (XNAS). He has 4 filings in total, and across the 4 recent filings observed, the acquisitions and buys run from 2024-02-07 to 2026-03-03, with total buy volume of EUR 46659 and no sell volume indicated.